International Scholarly Research Notices / 2012 / Article / Fig 4

Clinical Study

Treatment of Primary Axillary Hyperhidrosis with Botulinum Toxin Type A: Our Experience in 50 Patients from 2007 to 2010

Figure 4

100 U of Botox (Allergan, Inc., Irvine, CA, USA).

You are browsing a BETA version of Click here to switch back to the original design.